Kymab is Drug Discovery in United Kingdom that focus on developer business. Founded in 2010. They cover business area such as developer, novel human antibody-base therapy, indication, fully human monoclonal antibody therapeutic, response, immunization, antigen, healthcare provider, novel therapeutic antibody, cancer, autoimmune hematological disease.
2010
( 16 years old in 2026 )
Developer
-
The Bennet Building (B930)
Babraham Research Campus
Cambridge CB22 3AT
England, United Kingdom
Private
developernovel human antibody-base therapyindicationfully human monoclonal antibody therapeuticresponseimmunizationantigenhealthcare providernovel therapeutic antibodycancerautoimmune hematological disease
* We use standard office opening hours in near Kymab's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Kymab is Drug Discovery business from United Kingdom that founded in 2010 (16 years old in 2026), Kymab business is focusing on Developer.
Kymab headquarter office and corporate office address is located in The Bennet Building (B930) Babraham Research Campus Cambridge CB22 3AT England, United Kingdom.
Kymab was founded in United Kingdom.
In 2026, Kymab is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Kymab, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
